Morepen Laboratories Limited — Updates, 04-08-2026: Press Release
04-08-2026 | 02:06 pm
04-08-2026 | 02:06 pm
Morepen Labs hit record Q1'FY27 revenue of Rs 575.31 Cr (+34% YoY), EBITDA Rs 87.72 Cr (+207%), and PAT Rs 56.35 Cr (+394%). Its Rs 825 Cr CDMO mandate commenced full commercialization, with Rs 58 Cr dispatches. Strong API and Medical Devices growth supported performance.
No comments yet. Be the first to comment!
